Weaver C. Barksdale & Associates Inc. Sells 250 Shares of CVS Health Co. (NYSE:CVS)

Weaver C. Barksdale & Associates Inc. cut its holdings in CVS Health Co. (NYSE:CVS) by 1.4% in the second quarter, HoldingsChannel reports. The firm owned 17,634 shares of the pharmacy operator’s stock after selling 250 shares during the period. Weaver C. Barksdale & Associates Inc.’s holdings in CVS Health were worth $1,041,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of CVS. Gryphon Financial Partners LLC raised its stake in shares of CVS Health by 48.3% in the 4th quarter. Gryphon Financial Partners LLC now owns 8,151 shares of the pharmacy operator’s stock valued at $654,000 after acquiring an additional 2,653 shares in the last quarter. CreativeOne Wealth LLC raised its position in shares of CVS Health by 34.0% in the fourth quarter. CreativeOne Wealth LLC now owns 7,726 shares of the pharmacy operator’s stock valued at $610,000 after purchasing an additional 1,961 shares during the period. Financial Advisors Network Inc. acquired a new stake in shares of CVS Health in the fourth quarter worth $218,000. Allstate Corp boosted its holdings in shares of CVS Health by 13.3% during the 4th quarter. Allstate Corp now owns 4,207 shares of the pharmacy operator’s stock worth $332,000 after buying an additional 493 shares during the period. Finally, BCU Wealth Advisors LLC acquired a new position in CVS Health in the 4th quarter valued at $598,000. 80.66% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have weighed in on CVS shares. Evercore ISI cut their target price on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research note on Monday. Barclays lowered their target price on CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft cut their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $68.00 target price on shares of CVS Health in a research report on Wednesday, September 4th. Eleven investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $72.10.

CVS Health Stock Down 0.0 %

Shares of CVS opened at $58.40 on Friday. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The stock has a market cap of $73.31 billion, a price-to-earnings ratio of 10.26, a P/E/G ratio of 0.79 and a beta of 0.53. The company has a 50-day moving average price of $58.34 and a two-hundred day moving average price of $62.71. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same quarter in the previous year, the firm earned $2.21 EPS. CVS Health’s quarterly revenue was up 2.6% on a year-over-year basis. Equities analysts predict that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.55%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s dividend payout ratio is currently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.